---

Case Summary: Ramesh - Grade II Cellulitis

Patient Profile

---

Chief Complaint

---

Significant Past History

• Left-sided CVA - 4 months ago
• Type 2 Diabetes Mellitus (T2DM) - on treatment
• Systemic Hypertension (SHTN) - on treatment
• No prior surgeries, no known drug allergies

---

Vitals on Admission

---

Systemic Examination

• CVS: S1, S2 heard, no added sounds
• RS: Normal vesicular breath sounds
• CNS: No focal neurological deficit (residual CVA status)
• Abdomen: Soft

---

Investigations

Hematology

Renal Function Tests

Liver Function Tests

---

Provisional Diagnosis

---

In-Hospital Treatment Chart (as documented)

---

Discharge Medication Plan

---

1. Antibiotic (Step-down from IV Cefoperazone-Sulbactam)

• Rationale: Covers Streptococcus and Staphylococcus (the two main cellulitis pathogens). Appropriate step-down after parenteral beta-lactam/beta-lactamase inhibitor therapy. Mild renal impairment (Cr 1.5) - this dose is acceptable but reduce frequency if CrCl < 30.
• If MRSA risk is suspected: Tab. Clindamycin 300 mg TDS x 7 days is an alternative.

---

2. Diabetic Management

• OR coordinate with existing antidiabetic regimen from prior treating physician
• Target perioperative/discharge glucose < 200 mg/dL
• Strict blood glucose monitoring at home

---

3. Antihypertensive (continue existing)

• Patient's BP well-controlled at 130/80 - continue same dose
• If the patient was also on any other antihypertensive (e.g., ARB/ACE-I) for post-CVA care, continue those as per neurology advice

---

4. Antiplatelet (Post-CVA - likely already on this)

• Patient had a left CVA 4 months ago - antiplatelet therapy is standard unless contraindicated. Verify current neuro prescription.

---

5. Gastroprotection

• Continue PPI coverage, especially with antibiotics + aspirin combination

---

6. Wound Care Instructions (Non-pharmacological - per 2025 systematic review, PMID 40530782)

• Limb elevation - keep left leg elevated above heart level when resting (reduces edema and speeds healing)
• Daily wound dressing - clean with normal saline, apply antiseptic (povidone-iodine or chlorhexidine) dressing
• Compression bandaging if venous insufficiency suspected (post-wound healing phase)
• Strict glucose control to improve wound healing
• Avoid walking barefoot; use protective footwear

---

7. Micronutrient Supplementation

• Supports wound healing, immune function (patient has mild anemia and chronic ulcer)

---

Iron Supplementation (for mild normocytic anemia)

• Hb 11.1 g/dL with chronic ulcer and possible nutritional deficiency - oral iron is appropriate

---

Monitoring Instructions at Discharge

---

Red Flags - Return Immediately if:

• Temperature > 38.5°C (fever)
• Rapid spread of erythema beyond marked borders
• Development of blistering, bullae, or blackening (risk of necrotizing fasciitis)
• Decreased urine output (acute kidney injury)
• Confusion or new neurological symptoms (post-CVA watch)

---

Clinical note: The mildly elevated creatinine (1.5 mg/dL) and elevated total bilirubin (3.2 mg/dL) require follow-up at 1 week to check for drug-induced changes. The post-CVA status mandates antiplatelet continuation and BP control. Given the 5-year chronic ulcer history with T2DM, long-term wound care and podiatry/vascular surgery review should be arranged.

• S.No 5 - Tab. Adving → Generic: likely Aceclofenac ... wait, no - S.No 5 is "Tab. Adving" (Adenosine? or more likely a brand)
• S.No 7 - Tab. Poallo (Paollo?)

---

S.No 5 - Tab "Adving/Adolvig" → Aceclofenac

• Post-injury/ulcer pain relief
• Reduces local soft tissue inflammation around the cellulitis site
• Better GI tolerability than diclofenac

• Creatinine is mildly elevated (1.5 mg/dL) - use with caution, ensure adequate hydration; NSAIDs can worsen renal function
• Should be taken strictly after food
• Covered by PPI (pantoprazole) for GI protection

---

S.No 7 - Tab "Poallo/Panllo" → Pantoprazole + Levosulpiride (Panlo / similar brand)

• Pantoprazole (PPI) - suppresses gastric acid by irreversibly inhibiting H⁺/K⁺-ATPase proton pump
• Levosulpiride (prokinetic + antidopaminergic) - enhances gastric motility, reduces bloating and nausea, has mild antiemetic properties

• Gastroprotection against the NSAIDs (aceclofenac S.No 5) and antibiotics (cefoperazone-sulbactam)
• Levosulpiride component addresses gastric discomfort, nausea, or dyspepsia that can occur with IV antibiotics
• Also protects against stress ulceration during hospitalization

---

Important Notes for This Patient

---

Duration of Admission

---

What the case tells us

---

Expected Duration Based on Clinical Parameters

Criteria for Discharge in This Case

1. Leukocytosis resolves - WBC returning toward normal (currently 15.92 × 10³/µL)
2. Wound discharge stops or significantly reduces
3. Tachycardia resolves (currently PR 104/min)
4. Tolerating oral antibiotics - step-down from IV cefoperazone-sulbactam
5. Blood glucose controlled (T2DM management optimized)
6. Creatinine stable or improving

---

---

Goals of Therapy — Ramesh, 52M, Grade II Cellulitis

1. PRIMARY GOAL — Eradicate the Infection

---

2. WOUND HEALING GOAL

---

3. COMORBIDITY CONTROL GOALS

Diabetes (T2DM)

Hypertension

Post-CVA (4 months ago)

---

4. RENAL PROTECTION GOAL

---

5. HEPATIC MONITORING GOAL

---

6. ANEMIA CORRECTION GOAL

---

7. SAFE STEP-DOWN AND DISCHARGE GOAL

---

8. LONG-TERM PREVENTION GOAL

---

Summary in One Line Per Drug

1. Inj. Magnex - Cefoperazone + Sulbactam 1.5g BD
2. Inj. Pan - Pantoprazole 40mg OD
3. Inj. Para - Acetaminophen (Paracetamol) 1g TDS
4. Tab. Chymoral Forte - Trypsin + Chymotrypsin TDS
5. Tab. Gremer - Glimepiride 500mg BD (this corrects earlier reading - it's a sulfonylurea for his T2DM)
6. Tab. Aston - Aceclofenac 100mg OD
7. Tab. Papulo - Palmitoylethanolamide (PEA) 100mg OD (neuropathic pain/anti-inflammatory)
8. Tab. Amlog - Amlodipine 5mg OD

---

Drug-Drug Interactions (DDI)

🔴 MAJOR / CLINICALLY SIGNIFICANT

---

---

---

---

---

🟡 MODERATE

---

---

---

---

Drug-Food Interactions (DFI)

---

Summary of Key Clinical Alerts for Ramesh

Drug-Drug Interactions (DDI)

• Glimepiride + Aceclofenac → NSAID displaces sulfonylurea from protein binding → ↑ hypoglycemia risk → monitor glucose closely
• Aceclofenac + Amlodipine → NSAID causes Na⁺/water retention → ↓ antihypertensive effect → monitor BP daily
• Cefoperazone + Paracetamol → both hepatically metabolized → additive liver burden → monitor LFTs (bilirubin already 3.2 mg/dL)

• Glimepiride + Cefoperazone → antibiotic potentiates insulin secretion → ↑ hypoglycemia risk → monitor glucose BD-TDS
• Pantoprazole + Glimepiride → PPI inhibits CYP2C19 → ↑ glimepiride levels → hypoglycemia risk
• Aceclofenac + Paracetamol → additive GI irritation → covered by pantoprazole → acceptable short-term

• Trypsin-Chymotrypsin + Cefoperazone → may enhance antibiotic tissue penetration → generally beneficial

---

Drug-Food Interactions (DFI)

• Glimepiride + Alcohol → severe hypoglycemia + flushing → strictly avoid alcohol
• Glimepiride + food → take 30 min before meals; eat at consistent times
• Aceclofenac + empty stomach/spicy food → GI irritation → always take after food
• Aceclofenac + Alcohol → additive GI mucosal damage → avoid alcohol
• Amlodipine + Grapefruit → inhibits CYP3A4 → ↑ amlodipine levels → hypotension → avoid grapefruit completely
• Pantoprazole + food → take 30 min before breakfast for best efficacy
• Paracetamol + Alcohol → additive hepatotoxicity → strictly avoid (bilirubin already high)
• Cefoperazone + Alcohol → disulfiram-like reaction → flushing, vomiting, hypotension → absolute prohibition during treatment and 72 hrs after

---

Top 3 Alerts for Ramesh

1. 🔴 Hypoglycemia - Glimepiride + Aceclofenac + Cefoperazone all interact → monitor glucose frequently
2. 🔴 No alcohol at all - Cefoperazone causes disulfiram reaction; paracetamol adds liver toxicity
3. 🔴 Monitor LFTs - bilirubin already elevated + multiple hepatically metabolized drugs on board

---

ASSESSMENT

Standard Therapy

• IV beta-lactam/beta-lactamase inhibitor antibiotic (e.g., Amoxicillin-Clavulanate or Cefoperazone-Sulbactam)
• Analgesic/antipyretic (Paracetamol)
• PPI for gastroprotection
• Anti-inflammatory enzyme (Trypsin-Chymotrypsin) for edema
• Limb elevation
• Wound dressing with antiseptic
• Blood glucose control in diabetic patients
• Antihypertensive continuation
• Antiplatelet therapy in post-CVA patients

---

Current Therapy

• Inj. Cefoperazone-Sulbactam 1.5g IV BD
• Inj. Pantoprazole 40mg IV OD
• Inj. Paracetamol 1g IV TDS
• Tab. Chymoral Forte (Trypsin-Chymotrypsin) TDS
• Tab. Gremer (Glimepiride 500mg) BD
• Tab. Aston (Aceclofenac 100mg) OD
• Tab. Papulo (Palmitoylethanolamide 100mg) OD
• Tab. Amlog (Amlodipine 5mg) OD

---

Justification for Change

• Aceclofenac - caution: interacts with Glimepiride (↑ hypoglycemia risk) and Amlodipine (↓ antihypertensive effect); creatinine mildly elevated (1.5 mg/dL) - monitor renal function; consider dose reduction
• Paracetamol - bilirubin elevated (3.2 mg/dL); limit dose to ≤ 2g/day; monitor LFTs
• Glimepiride - dose adjustment may be needed given mild renal impairment; monitor blood glucose frequently
• Add Antiplatelet (Aspirin/Clopidogrel) - patient had CVA 4 months ago; confirm if already on it from neurology
• Add Iron/B-complex supplementation for mild anemia (Hb 11.1 g/dL)
• Add Electrolyte correction: Na⁺ 133 mEq/L (mild hyponatremia), K⁺ 3.3 mEq/L (borderline low)

---

GOALS OF THERAPY

• Eradicate bacterial infection → normalize WBC (< 11 × 10³/µL), ANC, resolve neutrophilia
• Resolve local signs of cellulitis → no erythema, swelling, warmth, discharge
• Promote wound healing of chronic left leg ulcer
• Normalize pulse rate (currently 104/min)
• Maintain blood glucose (FBS 80-130 mg/dL; PPBS < 180 mg/dL)
• Control BP < 130/80 mmHg
• Prevent recurrent CVA → continue antiplatelet
• Stabilize/improve renal function (creatinine ≤ 1.2 mg/dL)
• Normalize bilirubin and LFTs
• Correct mild anemia (Hb > 13 g/dL)
• Safe step-down to oral antibiotics before discharge

---

PLAN

• Continue IV Cefoperazone-Sulbactam; plan step-down to oral Amoxicillin-Clavulanate 625mg BD after 5-7 days if clinical improvement
• Monitor blood glucose BD-TDS (Glimepiride + Aceclofenac + Cefoperazone interaction risk)
• Monitor BP daily (Aceclofenac reduces amlodipine efficacy)
• Monitor LFTs and creatinine at Day 5 and discharge (elevated bilirubin + mild renal impairment)
• Limit paracetamol ≤ 2g/day given elevated bilirubin
• Correct electrolytes: oral/IV sodium and potassium supplementation
• Daily wound dressing with antiseptic; mark erythema borders to track spread
• Elevate left lower limb to reduce edema
• Strict alcohol prohibition (cefoperazone - disulfiram reaction)
• Patient counselling: glucose monitoring, BP monitoring, wound care, footwear
• Arrange follow-up at 1 week post-discharge: repeat CBC, RFT, LFT, wound review
• Refer to neurology for antiplatelet review (post-CVA 4 months)

---

DOB: 03/08/26 visible on the sheet confirms discharge date is 3rd August 2026, meaning the patient was admitted 28/07/26 and discharged 03/08/26 - a total of 6 days of inpatient stay.

ASSESSMENT

• IV beta-lactam antibiotic + PPI + analgesic + anti-inflammatory enzyme
• Limb elevation + wound dressing
• Blood glucose & BP control

• Inj. Cefoperazone-Sulbactam 1.5g BD
• Inj. Pantoprazole 40mg OD
• Inj. Paracetamol 1g TDS
• Tab. Chymoral Forte TDS
• Tab. Glimepiride 500mg BD
• Tab. Aceclofenac 100mg OD
• Tab. Palmitoylethanolamide 100mg OD
• Tab. Amlodipine 5mg OD

• Aceclofenac → interacts with Glimepiride (↑ hypoglycemia) + Amlodipine (↓ BP control); caution with Cr 1.5 mg/dL
• Paracetamol → limit ≤ 2g/day; bilirubin elevated (3.2 mg/dL)
• Add antiplatelet (post-CVA)
• Add iron + B-complex (Hb 11.1 g/dL)
• Correct Na⁺ (133) and K⁺ (3.3)

---

GOALS OF THERAPY

• Eradicate infection → normalize WBC, resolve erythema/discharge
• Control glucose (FBS 80-130, PPBS < 180 mg/dL)
• Maintain BP < 130/80 mmHg
• Heal chronic leg ulcer
• Normalize creatinine, bilirubin, Hb
• Prevent recurrent CVA

---

PLAN

• Step-down to oral Amoxicillin-Clavulanate 625mg BD after 5-7 days
• Monitor glucose BD-TDS, BP daily, LFT + RFT at Day 5
• Daily wound dressing + limb elevation
• Correct electrolytes
• Strict alcohol prohibition (disulfiram reaction with cefoperazone)
• Follow-up at 1 week: CBC, RFT, LFT, wound review
• Neurology referral for antiplatelet review

Pharmacist Interventions for Ramesh's Case

---

1. Drug Therapy Problem (DTP) Identification

---

2. Medication Reconciliation

• Verify patient's pre-admission medications (antidiabetic + antihypertensive + post-CVA drugs)
• Ensure no duplication of drugs from home medications
• Confirm antiplatelet status from neurology prescription

---

3. Dose Optimization

• Glimepiride - check if 500mg BD is appropriate with mild renal impairment (Cr 1.5); consider dose reduction
• Paracetamol - reduce to BD from TDS given raised bilirubin
• Cefoperazone-Sulbactam - confirm dose is appropriate for renal function (CrCl-based adjustment if needed)

---

4. Therapeutic Drug Monitoring (TDM) Recommendations

---

5. Patient Counselling (at Discharge)

• Take Glimepiride 30 min before meals - never skip meals after taking it
• Take Aceclofenac and Paracetamol after food only
• Take Pantoprazole 30 min before breakfast
• Take Amlodipine at the same time daily
• No alcohol - risk of severe hypoglycemia + disulfiram reaction with cefoperazone even after discharge (72 hrs)
• No grapefruit with Amlodipine

• Check blood glucose daily at home
• Check BP daily
• Watch wound for spreading redness, fever, pus → return immediately
• Keep left leg elevated when resting
• Wear protective footwear at all times (diabetic foot care)

• Sweating, trembling, confusion (hypoglycemia)
• Fever > 38.5°C
• Wound spreading or blackening
• Reduced urine output
• New weakness or speech difficulty (stroke recurrence)

---

6. Pharmacist Communication to Physician

Recommendations to raise with the treating doctor:

• 🔴 Add antiplatelet therapy (Aspirin 75mg) for secondary stroke prevention
• 🔴 Review Aceclofenac use - DDI with Glimepiride + renal concern
• 🟡 Add iron + B-complex for anemia correction
• 🟡 Correct electrolyte imbalances (Na⁺, K⁺)
• 🟡 Plan oral step-down antibiotic for discharge

---

7. Discharge Medication Counselling Checklist

• Patient understands each drug's purpose
• Patient knows correct timing of each drug
• Hypoglycemia symptoms explained
• Wound care technique demonstrated
• Follow-up date given (1 week)
• Emergency contact provided
• Alcohol and grapefruit avoidance confirmed
• Blood glucose and BP monitoring taught

Patient Counselling — Ramesh, 52M, Grade II Cellulitis

---

🧑‍⚕️ Introduction

---

💊 1. Medication Counselling

---

🍽️ 2. Diet Counselling

• Eat meals at fixed times every day (important for diabetes)
• Include protein-rich foods - eggs, dal, fish, chicken - for wound healing
• Eat green leafy vegetables - spinach, fenugreek - for iron and vitamins
• Drink 8-10 glasses of water daily (keeps kidneys healthy)
• Eat low-salt food (BP control)
• Eat low-sugar, low-carb diet (diabetes control)

• ❌ No alcohol - extremely dangerous with your medicines (blood sugar crash + liver damage)
• ❌ No grapefruit or grapefruit juice - reacts with BP medicine
• ❌ No fried, oily, or very spicy food
• ❌ No skipping meals when on Glimepiride

---

🦶 3. Wound & Leg Care Counselling

• Clean the wound daily with normal saline or clean water
• Apply dressing as advised by doctor - keep wound covered
• Elevate your left leg on a pillow whenever sitting or lying down - reduces swelling
• Never walk barefoot - always wear protective footwear
• Check your feet daily for new cuts, blisters, or redness
• Do not scratch the wound area
• Change socks daily; wear clean, soft cotton socks

---

🩺 4. Monitoring at Home

---

⚠️ 5. Warning Signs - Come to Hospital Immediately If:

• 🔴 Sweating, trembling, confusion, weakness → low blood sugar (hypoglycemia)
• 🔴 Fever above 38.5°C
• 🔴 Wound spreading, turning black, blistering, or very smelly
• 🔴 Reduced or no urine output
• 🔴 Sudden weakness of hand/leg or slurred speech → possible stroke
• 🔴 Severe stomach pain or yellow eyes → liver problem

---

🚭 6. Lifestyle Counselling

• No alcohol - absolute prohibition
• No smoking - impairs wound healing and worsens BP
• Light walking is okay after wound improves - do not strain the leg
• Reduce stress - stress raises blood glucose and BP
• Sleep 7-8 hours daily - promotes healing

---

📅 7. Follow-Up Instructions

• Visit hospital after 1 week (03/08/26 discharge → follow-up ~10/08/26)
• Carry all medicines and previous reports
• Tests to be repeated at follow-up:
  • Blood glucose (FBS + PPBS)
  • Kidney function test (creatinine)
  • Liver function test (bilirubin)
  • Complete blood count (Hb, WBC)
  • Wound review by surgeon

---

📝 8. Key Messages to Remember

1. Take medicines regularly - never stop on your own
2. No alcohol - it is dangerous with your medicines
3. Check sugar and BP daily at home
4. Keep leg elevated and wound clean
5. Eat on time - never skip meals
6. Return immediately if wound worsens or you feel faint/confused

Lifestyle Modifications for Ramesh

---

🍽️ 1. Diet

• Eat small, frequent meals at fixed times (every 3-4 hrs)
• High protein diet - eggs, dal, lean meat, fish - for wound healing
• Green leafy vegetables - spinach, methi - for iron and vitamins
• Fruits - papaya, guava, amla - rich in Vitamin C (promotes healing)
• Drink 8-10 glasses of water daily
• Use low-salt cooking (< 5g/day) for BP control
• Prefer whole grains - brown rice, ragi, oats - over refined carbs

• ❌ No sugar, sweets, maida, white rice in excess
• ❌ No fried, oily, processed, junk food
• ❌ No pickles, papad, canned food (high sodium → raises BP)
• ❌ No alcohol - absolute prohibition
• ❌ No grapefruit

---

🚶 2. Physical Activity

• Currently - rest with left leg elevated until wound heals
• After wound heals:
  • Start with gentle walking 10-15 min/day
  • Gradually increase to 30 min brisk walking 5 days/week
  • No heavy lifting or strenuous exercise
  • No prolonged standing - increases leg edema
• Simple hand and upper body exercises can be done during recovery
• Post-CVA physiotherapy - continue as advised by neurologist

---

🦶 3. Foot & Skin Care (Critical in Diabetic Patient)

• Never walk barefoot - indoors or outdoors
• Wear soft, well-fitting cotton socks and protective footwear daily
• Inspect both feet daily for cuts, blisters, redness, swelling
• Wash feet with lukewarm water (not hot) and dry between toes
• Apply moisturizer on dry skin - avoid between toes
• Trim nails straight across - never cut corners
• Change dressing daily on wound as instructed
• Report any new wound, color change, or bad smell immediately

---

🩺 4. Disease Management

• Monitor blood glucose daily - fasting every morning
• Take Glimepiride 30 min before meals - never skip food after
• Carry glucose tablets or candy always for hypoglycemia
• Target HbA1c < 7%

• Take Amlodipine same time every day - never miss
• Reduce salt intake strictly
• Monitor BP daily at home
• Target BP < 130/80 mmHg

• Take antiplatelet medicine as prescribed by neurologist
• Attend physiotherapy sessions regularly
• Watch for stroke warning signs - FAST:
  • Face drooping
  • Arm weakness
  • Speech difficulty
  • Time to call emergency

---

🚭 5. Habits to Stop

---

😴 6. Sleep & Stress

• Sleep 7-8 hours every night - essential for immune function and wound healing
• Avoid stress - stress raises blood glucose and BP
• Practice deep breathing or relaxation for 10 min daily
• Family support is important - involve family in care routine

---

🧴 7. Personal Hygiene

• Bathe daily with mild soap and lukewarm water
• Keep the wound area clean and dry
• Change clothes and underwear daily
• Keep home floor clean and dry to avoid fall injuries (post-CVA balance issues)
• Use non-slip footwear at home to prevent falls

---

📋 Summary Card for Ramesh

---

CLINICAL PROGRESS TABLE

---

---

CURRENT DRUG REGIMEN IN WARD

---

Tips for Writing Clinical Progress

• Progress column → Write patient symptoms, vitals, wound condition that day
• Investigation column → Write lab values ordered or reviewed that day
• Plan column → Write what was done / changed / continued that day
• Keep each entry brief - 2 to 3 lines per day
• Note visible improvement daily - "wound discharge reduced," "erythema borders receding," "PR normalizing"

Important Note First

---

Drugs Used for Tachycardia (General)

Classification Based on Type of Tachycardia

---

1. Sinus Tachycardia (like Ramesh's case)

---

2. Supraventricular Tachycardia (SVT)

---

3. Atrial Fibrillation / Flutter (Rate Control)

---

4. Ventricular Tachycardia (VT)

---

5. Wolff-Parkinson-White (WPW) Syndrome

---

Drug Classification (Vaughan Williams)

---

⚠️ In Ramesh's Case Specifically

Specific Investigations for Ramesh's Case

---

🔬 1. For Infection / Cellulitis

---

🩸 2. For Hematology (already done - repeat/add)

---

🧪 3. For Diabetes

---

🫀 4. For Hypertension & Cardiovascular

---

🧠 5. For Post-CVA Monitoring

---

🫘 6. For Renal Function (Creatinine 1.5 ↑)

---

🫀 7. For Liver (Bilirubin 3.2 ↑)

---

🦵 8. Specific to Wound / Leg Ulcer

---

📊 Priority Order for This Patient